The overwhelming majority of<unk>  <unk>  is seen in people with cancer, especially leukaemia, who receive chemotherapy with a cytotoxic drug. These include: Bleomycin, chlorambucil, cyclophosphamide, cytarabine, doxorubicin, lomustine, mitoxantrone, topotecan, and vincristine.<unk>  was first described in 1982 in a patient with acute myeloid leukaemia (AML) who had received cytarabine as chemotherapy. Cancer itself, infections, and other medicinal drugs also can lead to<unk> .<unk>  has been reported in patients with cancer who have not received any form of chemotherapy (i.e., as a paraneoplastic syndrome), in patients with HIV and/or AIDS, and after the use of paracetamol (acetaminophen). Also the use of targeted agents can lead to<unk> , e.g. imatinib, a tyrosine kinase inhibitor.<unk>  has also been described without any known reason (idiopathic cases), including idiopathic cases in children. The exact cause of<unk>  is unknown. In patients receiving chemotherapy, it has been postulated that a high concentration of the cytotoxic drug in sweat has a direct toxic effect on the<unk>  glands.
Neutrophilic eccrine hidradenitis
Diabetic dermadrome
Acroangiodermatitis
Contact granuloma
Phytophotodermatitis
Ichthyosis bullosa of Siemens
Dermal cylindroma
Granulomatous facial dermatitis